ULURU

ULURU develops and commercializes wound care and muco-adhesive film products for the United States and international markets.

ULURU Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of wound care and muco-adhesive film products in the United States and internationally. The company’s products are based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as surgical, acute, and chronic wounds; Aphthasol and Aptheal for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a muco-adhesive disc product for the treatment and management of oral pain. The company is based in Addison, Texas.